You are here

Article Text

Article menu
Download PDFPDF
Editorial
Making the case for advance provision of mifepristone and misoprostol for abortion in the United States

https://doi.org/10.1136/bmjsrh-2021-201321

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Twitter @K_Ehrenreich, @BiggsAntonia, @DrDGrossman

    • Correction notice This paper has been updated since it was first published. The funder name has been corrected.

    • Funding This study was funded by Fidelity Charitable.

    • Competing interests None declared.

    • Patient and public involvement Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.

    • Provenance and peer review Not commissioned; externally peer reviewed.